Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,076 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Refining TNM-8 M1 categories with anatomic subgroups for previously untreated de novo metastatic nasopharyngeal carcinoma.
Chan SK, Lin C, Huang SH, Chau TC, Guo QJ, O'Sullivan B, Lam KO, Chau SC, Chan SY, Tong CC, Vardhanabhuti V, Kwong DLW, So TH, Ng CY, Leung TW, Luk MY, Lee AWM, Choi HCW, Pan JJ, Lee VHF. Chan SK, et al. Among authors: chan sy. Oral Oncol. 2022 Mar;126:105736. doi: 10.1016/j.oraloncology.2022.105736. Epub 2022 Feb 1. Oral Oncol. 2022. PMID: 35121396
Metronomic oral cyclosphosphamide as third-line systemic treatment or beyond in patients with inoperable locoregionally advanced recurrent or metastatic nasopharyngeal carcinoma.
Lee VHF, Kwong DLW, Lam KO, Lai YC, Li Y, Tong CC, Ho PPY, Chan WL, Wong LS, Leung DKC, Chan SY, Chan FT, Leung TW, Lee AWM. Lee VHF, et al. Among authors: chan ft, chan wl, chan sy. Medicine (Baltimore). 2017 Apr;96(15):e6518. doi: 10.1097/MD.0000000000006518. Medicine (Baltimore). 2017. PMID: 28403082 Free PMC article. Clinical Trial.
The addition of pretreatment plasma Epstein-Barr virus DNA into the eighth edition of nasopharyngeal cancer TNM stage classification.
Lee VH, Kwong DL, Leung TW, Choi CW, O'Sullivan B, Lam KO, Lai V, Khong PL, Chan SK, Ng CY, Tong CC, Ho PP, Chan WL, Wong LS, Leung DK, Chan SY, So TH, Luk MY, Lee AW. Lee VH, et al. Among authors: chan wl, chan sk, chan sy. Int J Cancer. 2019 Apr 1;144(7):1713-1722. doi: 10.1002/ijc.31856. Epub 2018 Dec 24. Int J Cancer. 2019. PMID: 30192385 Free article. Clinical Trial.
Negative plasma Epstein-Barr virus DNA nasopharyngeal carcinoma in an endemic region and its influence on liquid biopsy screening programmes.
Nicholls JM, Lee VH, Chan SK, Tsang KC, Choi CW, Kwong DL, Lam KO, Chan SY, Tong CC, So TH, Leung TW, Luk MY, Khong PL, Lee AW. Nicholls JM, et al. Among authors: chan sk, chan sy. Br J Cancer. 2019 Oct;121(8):690-698. doi: 10.1038/s41416-019-0575-6. Epub 2019 Sep 17. Br J Cancer. 2019. PMID: 31527689 Free PMC article.
Prognostication of Half-Life Clearance of Plasma EBV DNA in Previously Untreated Non-metastatic Nasopharyngeal Carcinoma Treated With Radical Intensity-Modulated Radiation Therapy.
Chan SK, Chan SY, Choi HC, Tong CC, Lam KO, Kwong DL, Vardhanabhuti V, Leung TW, Luk MY, Lee AW, Lee VH. Chan SK, et al. Among authors: chan sy. Front Oncol. 2020 Aug 21;10:1417. doi: 10.3389/fonc.2020.01417. eCollection 2020. Front Oncol. 2020. PMID: 32974150 Free PMC article.
Comparison of efficacy and safety of three induction chemotherapy regimens with gemcitabine plus cisplatin (GP), cisplatin plus fluorouracil (PF) and cisplatin plus capecitabine (PX) for locoregionally advanced previously untreated nasopharyngeal carcinoma: A pooled analysis of two prospective studies.
Chan SK, Chan SY, Tong CC, Lam KO, Kwong DL, Leung TW, Luk MY, Lee AW, Choi HC, Lee VH. Chan SK, et al. Among authors: chan sy. Oral Oncol. 2021 Mar;114:105158. doi: 10.1016/j.oraloncology.2020.105158. Epub 2021 Jan 25. Oral Oncol. 2021. PMID: 33508707
1,076 results